AzTrials
AzTrials

White Spot LesionsNCT05733676

Comparison of MI Paste Plus and Resin Infiltration in White Spot Lesions Following Orthodontic Treatment

A study testing Resin infiltration and Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - Fluoride in people with White Spot Lesions and Orthodontic Appliance Complication, run by University of Alberta at 1 site in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Dental cavities are among the most frequent diseases that affect teeth, particularly in patients who are treated with braces due to the difficulty in maintaining good oral hygiene in the presence of the mouth appliances. Read more about this study

Who is it for?
Ages 12 to 21 yearsHealthy volunteers can take part
What is being tested?
Resin infiltration and Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - Fluoride
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
62 participants
Where
1 siteCanada
Study dates
30 May 2023to 1 Oct 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 21 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Individuals in the age range of 12-21 years who had undergone fixed orthodontic appliance therapy for a duration of 12-36 months.
  • Should have at least one white spot lesion on the labial surface of either maxillary or mandibular anterior teeth after debonding. Lesion visible with or without drying the lesion surface.
  • Patients with mild to moderate plaque accumulation. Fair oral hygiene. With a simplified Oral Hygiene Index of no more than 1.3-3.0

Who cannot join

  • Poor oral hygiene Simplified Oral Hygiene Index of 3.1-6.0 or more
  • Patients with hypoplasia or any developmental defects on the buccal of upper or lower incisors
  • Patients with any restorations on the buccal of upper or lower incisors
  • Patients that have presented WSL on the buccal of upper or lower incisors before orthodontic treatment was initiated.
  • Patients that have received any re-mineralizing agent other than regular toothpaste during the last three months
  • Patient with allergy to milk or any of their products
  • Patient with any medical / oral or mental condition
  • Patients or legal guardians that does not speak or read English

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ida M Kornerup, DMD, MEd contact

780 492 7100

kornerup@ualberta.ca

Nancy Abdelhay, DMD, PhD contact

780 492 7100

abdelhay@ualberta.ca

Canada1 site, 1 recruiting
  • KAYE Edmonton Clinic

    Edmonton, Alberta, T6G 1Z1

    Doris Lunardon, DDS, 780 407 5572, lunardon@ualberta.ca

    Melanie Chouinard, 780 407 5552, mchouina@ualberta.ca

    Recruiting

Other trials in Canada

About this study

Official title: Comparison of MI Paste Plus and Resin Infiltration in Improvement of White Spot Lesions Following Fixed Orthodontic Treatment: A Randomized Controlled Trial

Dental cavities are among the most frequent diseases that affect teeth, particularly in patients who are treated with braces due to the difficulty in maintaining good oral hygiene in the presence of the mouth appliances. The white spot lesion (WSL) is the first clinical sign of cavities that presents itself as a milky-white opacity when located on the front face of the tooth. The aim to manage these early lesions focuses on promoting natural remineralization and preventing further demineralization. Various materials have been introduced for management of WSLs including MI paste and MI paste combined with fluoride (MI paste plus). Recently, a new material called resin infiltration has been found to treat these lesions with high esthetic results and great performance. According to the few numbers of in-vivo studies investigating the effectiveness of remineralization products, the aim of the current study is to clinically compare the outcome of the resin-infiltration and etching + MI paste plus to stop and improve the appearance of the WSL on front teeth in patients after treatment with braces.

Read the detailed description

White spot lesion (WSL) is the first clinical sign of enamel caries that presents itself as a milky-white opacity non-cavitated when located on smooth surfaces. These surfaces are rougher than sound enamel, and they can be arrested or progressed. WSLs are more commonly seen on the outer surface of teeth after orthodontics treatment. Causing unaesthetic appearance on the anterior teeth and increasing chance of dental caries progression.

Different interventions have been introduced to manage WSL as preventing demineralization and biofilm formation, and promoting remineralization with fluoride varnish, casein phosphopeptides-amorphous calcium phosphate (CPP-ACP)- a nano-complex derived from milk casein that significantly increases salivary calcium and phosphate levels9 .

The remineralization of enamel subsurface lesions by CPP-ACP has been demonstrated in several in vitro studies. The potential of CPP-ACP to prevent enamel demineralization and promote lesion remineralization has also been successfully demonstrated in human in situ models. In the presence of fluoride, CPP-ACP has been shown to promote the formation of fluorapatite-like minerals deep in the subsurface lesion. Clinical studies evaluating the effect of CPP-ACP/ACFP on WSLs after debonding report significant regression of WSL numbers, size, and activity in comparison to fluoride or substances without fluoride. Consequently, CPP-ACP has been incorporated into minimally invasive products for the remineralization of WSLs. Nevertheless, other studies state significant change showing improvements in WSLs with remineralization products but no superiority of CPP-ACP .

Multiple studies have tested the efficacy of CPP-ACP on post-orthodontic WSLs but only a limited number of prospective clinical studies have examined the effect of CPP-ACP and fluoride + etch on WSLs developed during orthodontic treatment. It is during therapy with fixed appliances that patients are most susceptible to forming WSLs and WSLs are most active. Recently, treatment with resin infiltration has been developed by the dentistry equipe at Charité University of Berlin, Germany and was first proposed to halt the interproximal early stage non-cavitated caries lesions. It represents a new concept in dentistry that offers valuable clinical applicability for clinicians and high acceptance by patients and is an alternative method to treat early caries lesions that are not expected to remineralize or arrest by non-invasive measures when the infiltration is performed with low-viscosity light-curing resins.

The refractive index (RI) of enamel lesions is effective in arresting and stabilizing the progress of WSLs. Paris et al noted that lesions infiltrated by resin infiltration took on the appearance of the surrounding sound enamel masking the whitish appearance by filling the lesion's body with resin, which results in a rise of the refractive index (RI) of the lesion from 1-1. to 1.42-1.44 with resin infiltration, which is closer to a healthy enamel (1.62-1.63). Thus, a restoration with enamel-like optical characteristics is obtained. This technique is considered micro-invasive and may bridge the gap between the non-invasive and minimally invasive treatment of WSLs, postponing the need for a restoration as long as possible.

According to few in-vivo studies investigating the effectiveness of remineralization products to address the appearance of WSLs after orthodontic treatment.

The aim of the current study is to assess clinically the change in the WSL appearance of the maxillary incisors in patients treated with resin-infiltration + etch compared with patients treated with CPP-ACFP plus +etch .

Hypothesis: No significant difference will be expected between CPP-ACFP +etch (MI paste plus + etch) and resin infiltration etch in terms of improving the WSL however, the esthetic outcome of resin infiltration + etch will be significantly greater compared to MI paste plus + etch.

Justification: Few studies have evaluated in vivo the WSL change satisfaction of resin infiltration compared to CPP-ACP and fluoride + etch after orthodontic treatment for more than a year for follow ups. In-vitro and in-vivo studies have shown a change in WSLs as a result of the topical use of these materials. However, further studies are needed to prove their role in calcium-based remineralization systems.

Objectives:

Determine the effect of resin infiltration and CPP-ACP in the caries process Determine the effect of resin infiltration and CPP-ACP in incisors aesthetics

Methods:

In this clinical randomized controlled trial study, sixty two subjects in the age range of 12-21 years having at least one post-orthodontic WSL on the upper or lower incisors will be randomly assigned to two groups of 31 samples in each. Participants will be recruited from patients who underwent labial fixed orthodontic treatment with (bracket properties), bonded with light-cured composite resin adhesive (Transbond XT, 3M Unitek, U.S.A) in the Department of Orthodontics, Dental School, University of Alberta. The study period will be from March 2023 and so on with prior approval from IRB (HERB). Informed consents will be obtained from parents/caregivers of the children after explaining the details of the treatment procedure in a designated format in regional and English languages.

Justification of the sample size :

Using results from Baffif et al. (2020), sample size is estimated based on the effect size demonstrated from ICON as compared at the 6 month level is a mean difference of 0.8 with a standard deviation of 1.3. Assuming power of 0.8 and alpha of 0.05, the required sample size is 31 per group.The selected samples will be randomly allocated to two groups according to treatment received.

Group I- Resin infiltration -Icon + etch, DMG, Germany, (n=31). Group II- MI paste plus +etch , GC corporation, Germany, Europe, (n=31). Before the application of topical agents on white spot lesions, oral prophylaxis will be carried out and the affected tooth to be treated will be cleaned with a rubber cup with prophylaxis paste (3M, Clinpro, United States of America) in both groups.

Information in regards to the length of orthodontic treatment, date of removal of orthodontic appliances, and oral hygiene status during treatment will be collected from the patients' charts. Patients will randomly receive an 8-week regimen of MI paste plus or resin infiltration. Patients will be followed up at 3,6, 12 and 18 months to evaluate change in appearance of the lesion of both treatments.

Plan for Data Analysis:

Remineralization will be assessed by the enamel decalcification index score (EDI) and International caries detection and assessment system (ICDAS) to evaluate the WSLs change after treatment with the two remineralizing agents. Furthermore, the satisfaction evaluation of the lesion will be assessed by a Visual Analog Scale (VAS) from 0 mm no change to 100 mm WSL completely changed/disappeared. The assessment will be done with photographs. Intraoral frontal views will be taken digitally. These photographs will be obtained at baseline (a few days after debonding to allow resolution of gingival inflammation that might mask WSLs), 3, 6,12 and 18 months after completion of orthodontic treatment. The patients will be asked to tilt up their head approximately 5-10 degrees to limit the flash reflection to the incisal third of the maxillary incisors. The optimal image will be selected among several photographs that will be taken at each time point. The first panel will consist of 3 dental experts (orthodontists and pediatric dentists) while the second panel will consist of three laypersons. Each examiner will perform the assessment independently.

Statistical analysis:

The collected data will be subjected to statistical analysis using SPSS version 22.0 (Armonk, NY, IBM Corp). Demographic variables will be analyzed using proportions. Independent sample 't' test will be used to compare the mean difference in esthetic appearance (VAS) and lesion.

Repeated Measures ANOVA will be used to determine the mean difference in VAS and EDI score, within study groups at various time intervals.

Expected results No significant difference will be expected between MI paste plus+etch and resin infiltration etch in terms of improving the WSL; however, the esthetic outcome of resin infiltration + etch will be significantly greater compared to MI paste plus + etch.

Study significance WSLs are prevalent lesions on the surface of teeth particularly, around the attached brackets, which lead to unaesthetic appearance of teeth after bracket removal and increase the chance of initiation of dental caries. Caries in the anterior teeth compromise the aesthetic enhancement achieved by orthodontic treatment. Thus, introducing a material that changes the WSL while providing the most similar appearance to the tooth enamel will be of great value.

Risks and Discomforts This technique has no risk or discomfort during the research, as both materials have been approved in Canada. Except that the application of CCP-ACP + fluoride may be difficult for some people as they need to use it at home. This material is contraindicated in patients with a proven or suspected milk protein allergy and/or with a sensitivity or allergy to benzoate preservatives. No side effects have been reported so far.

During the study visits, there may be an increased risk of COVID-19 exposure due to the added time spent within our health care facility and possible exposure to others. All AHS Infection Prevention and Control Practices in place during the pandemic (screening for COVID 19 symptoms prior to hospital entry, use of masks, hand sanitizer and physical distancing measure where possible) will also apply during these visits to reduce COVID- 19 risks.

There may be risks in this study that are currently not known. If the investigators find out anything new during the course of this research which may change participants' willingness to be in the study, the investigators will tell participants about these findings.

Being tested
Resin infiltration, Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - Fluoride
Keywords
White spot lesion, caries, arrested, orthodontic
Medical subject headings
Heart Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resin infiltrationDevice

    Base line treatment of white spot lesions in smooth surface with Resin infiltration -Icon + etch, DMG, Germany.

  • Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - FluorideDevice

    Base line treatment of white spot lesions in smooth surface with MI paste plus + etch , GC corporation, Germany, Europe

Study groups in NCT05733676
Study groupRoleWhat they receive
Resin InfiltrationActive comparatorResin infiltration of early intervention of caries lesion as a consequences of orthodontic treatment
Receives: Device: Resin infiltration; Device: Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - Fluoride
Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - FluorideActive comparatorCasein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - Fluoride early intervention of caries lesion as a consequences of orthodontic treatment
Receives: Device: Resin infiltration; Device: Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - Fluoride

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Remineralization as assessed by the Enamel Decalcification Index (EDI) score with values 0-3 in each of the four tooth surfaces

    Enamel decalcification index (EDI) score with values 0-3 in each of the four facial zones including mesial, distal, gingival, and occlusal surfaces around the approximate location of the debonded bracket it will represent the decalcification level based on clinical visual assessment of the tooth. The values will be recorded at baseline, 3, 6, 12,18 months. Tooth surfaces completely covered by gingiva or bonding material will be excluded. International caries detection and assessment system (ICDAS) with values 0-6 will be assigned to each tooth surface around the orthodontic bracket.

    Measured: 3 years

  2. Satisfaction evaluation of the white spot lesion (WSL) as assessed by a Visual Analog Scale (VAS) from 0 mm no change to 100 mm completely changed

    Intraoral frontal views will be taken at, 3, 6,12 and 18 months after completion of orthodontic treatment. This digital photography will be calibrated following protocols to standardize magnification, shade, and color. The images will be cropped to include the 4 incisors. Two independent, blinded panels will rate the WSL change using a visual analog scale (VAS) from 0 mm no change to 100 mm completely changed. The order of the participants will be shuffled so the bias resulted from examiner bias will be eliminated. The median value of the VAS will be selected as the representation for the percentage of change.

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2023
  2. Study start30 May 2023
  3. Primary completion1 Mar 2028 (estimated)
  4. Study completion1 Oct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The selected samples will be randomly allocated to two groups according to treatment received. Group I- Resin infiltration -Icon + etch, DMG, Germany. Group II- MI paste plus +etch , GC corporation, Germany, Europe,
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
62 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05733676
Sponsor's protocol ID
UAlberta-Pro00126739
Status last verified
Jun 2026
First submitted
8 Feb 2023
Last updated
30 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Teshome A, Muche A, Girma B. Prevalence of Dental Caries and Associated Factors in East Africa, 2000-2020: Systematic Review and Meta-Analysis. Front Public Health. 2021 Apr 29;9:645091. doi: 10.3389/fpubh.2021.645091. eCollection 2021.

    PubMed 33996722
  • Cochrane NJ, Saranathan S, Cai F, Cross KJ, Reynolds EC. Enamel subsurface lesion remineralisation with casein phosphopeptide stabilised solutions of calcium, phosphate and fluoride. Caries Res. 2008;42(2):88-97. doi: 10.1159/000113161. Epub 2008 Jan 15.

    PubMed 18204252
  • Iijima Y, Cai F, Shen P, Walker G, Reynolds C, Reynolds EC. Acid resistance of enamel subsurface lesions remineralized by a sugar-free chewing gum containing casein phosphopeptide-amorphous calcium phosphate. Caries Res. 2004 Nov-Dec;38(6):551-6. doi: 10.1159/000080585.

    PubMed 15528910
  • Cai F, Manton DJ, Shen P, Walker GD, Cross KJ, Yuan Y, Reynolds C, Reynolds EC. Effect of addition of citric acid and casein phosphopeptide-amorphous calcium phosphate to a sugar-free chewing gum on enamel remineralization in situ. Caries Res. 2007;41(5):377-83. doi: 10.1159/000104796.

    PubMed 17713338
  • Huang GJ, Roloff-Chiang B, Mills BE, Shalchi S, Spiekerman C, Korpak AM, Starrett JL, Greenlee GM, Drangsholt RJ, Matunas JC. Effectiveness of MI Paste Plus and PreviDent fluoride varnish for treatment of white spot lesions: a randomized controlled trial. Am J Orthod Dentofacial Orthop. 2013 Jan;143(1):31-41. doi: 10.1016/j.ajodo.2012.09.007.

    PubMed 23273358
  • Rechmann P, Bekmezian S, Rechmann BMT, Chaffee BW, Featherstone JDB. MI Varnish and MI Paste Plus in a caries prevention and remineralization study: a randomized controlled trial. Clin Oral Investig. 2018 Jul;22(6):2229-2239. doi: 10.1007/s00784-017-2314-9. Epub 2018 Jan 4.

    PubMed 29299732
  • Kielbassa AM, Muller J, Gernhardt CR. Closing the gap between oral hygiene and minimally invasive dentistry: a review on the resin infiltration technique of incipient (proximal) enamel lesions. Quintessence Int. 2009 Sep;40(8):663-81.

    PubMed 19639091
  • Askar H, Schwendicke F, Lausch J, Meyer-Lueckel H, Paris S. Modified resin infiltration of non-, micro- and cavitated proximal caries lesions in vitro. J Dent. 2018 Jul;74:56-60. doi: 10.1016/j.jdent.2018.03.010. Epub 2018 May 16.

    PubMed 29775637
  • Mazur M, Westland S, Guerra F, Corridore D, Vichi M, Maruotti A, Nardi GM, Ottolenghi L. Objective and subjective aesthetic performance of icon(R) treatment for enamel hypomineralization lesions in young adolescents: A retrospective single center study. J Dent. 2018 Jan;68:104-108. doi: 10.1016/j.jdent.2017.11.001. Epub 2017 Nov 28.

    PubMed 29104142
  • Paris S, Meyer-Lueckel H. Inhibition of caries progression by resin infiltration in situ. Caries Res. 2010;44(1):47-54. doi: 10.1159/000275917. Epub 2010 Jan 16.

    PubMed 20090328
  • Chen M, Li JZ, Zuo QL, Liu C, Jiang H, Du MQ. Accelerated aging effects on color, microhardness and microstructure of ICON resin infiltration. Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7722-7731. doi: 10.26355/eurrev_201909_18981.

    PubMed 31599398
  • Walsh T, Worthington HV, Glenny AM, Appelbe P, Marinho VC, Shi X. Fluoride toothpastes of different concentrations for preventing dental caries in children and adolescents. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007868. doi: 10.1002/14651858.CD007868.pub2.

    PubMed 20091655
  • Maheswari SU, Raja J, Kumar A, Seelan RG. Caries management by risk assessment: A review on current strategies for caries prevention and management. J Pharm Bioallied Sci. 2015 Aug;7(Suppl 2):S320-4. doi: 10.4103/0975-7406.163436.

    PubMed 26538870
  • Richter AE, Arruda AO, Peters MC, Sohn W. Incidence of caries lesions among patients treated with comprehensive orthodontics. Am J Orthod Dentofacial Orthop. 2011 May;139(5):657-64. doi: 10.1016/j.ajodo.2009.06.037.

    PubMed 21536209
  • Cruz CL, Edelstein BL. Linking orthodontic treatment and caries management for high-risk adolescents. Am J Orthod Dentofacial Orthop. 2016 Apr;149(4):441-2. doi: 10.1016/j.ajodo.2015.12.007. No abstract available.

    PubMed 27021443

Questions about this trial

What is this clinical trial studying?

A study testing Resin infiltration and Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - Fluoride in people with White Spot Lesions and Orthodontic Appliance Complication, run by University of Alberta at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ida M Kornerup, DMD, MEd (780 492 7100, kornerup@ualberta.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Remineralization as assessed by the Enamel Decalcification Index (EDI) score with values 0-3 in each of the four tooth surfaces (time frame: 3 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05733676, which also lists 38 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in